LNAI · Lunai Bioworks Inc.

Lunai Bioworks Inc Is A Biopharmaceutical Company. Through Its Subsidiaries, It Is Mainly Focused On Developing Allogeneic Cell And Gene Therapies To Promote Stronger Immune System Responses, Potentially For Long-Term Or Life-Long Cancer Remission In Some Of The Deadliest Cancers. The Group Is Engaged In The Development Of Renb-Dc11 And Renb-Dc20 (Potential Cell Therapeutic Vaccine Candidates For Different Types Of Cancer); A Proprietary Ai Platform That Analyzes Genetics To Provide Earlier And More Accurate Cancer Diagnosis; And Machine Learning Pipelines That Harmonize And Analyze Complex, Heterogeneous Datasets To Uncover Clinically Actionable Insights. The Group'S Reportable Segments Are: Renb, Biosymetrics, And Renc. Geographically, It Operates In The United States And Netherlands.